Sandia Investment Management »

Acelyrin shares owned by Sandia Investment Management

Quarter-by-quarter ownership of Acelyrin (SLRN) shares owned by Sandia Investment Management from 13F filings

Historical chart of Sandia Investment Management investment in Acelyrin

Tip: Access up to 7 years of quarterly data

All positions including Acelyrin held by Sandia Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Acelyrin by Sandia Investment Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $45k 6.0k 7.46
2023-09-30 $102k 10k 10.17
2023-06-30 $209k 10k 20.90

More positions owned by Sandia Investment Management

Sdcl Edge Acquisition Corp Cl A Ord Shs (SEDA)
Lavoro Class A Ord (LVRO)
Screaming Eagle Acquisitn Unit 01/05/2027 (SCRMU)
Haymaker Acquisition Corp Iv Unit 99/99/9999 (HYAC.U)
Dmy Squared Technology Group Cl A Com (DMYY)
Southport Acquisition Corp Cl A Com (PORT)
Sk Growth Opportunities Corp Class A Com (SKGR)
Nkgen Biotech (NKGN)
Concord Acquisition Corp Ii Com Cl A (CNDA)
Gores Holdings Ix Unit 01/14/2029 (GHIXU)
Churchill Capital Corp Vii Com Cl A (CVII)
Screaming Eagle Acquisitn Class A Ord Shs (SCRM)
Heico Corp Cl A (HEI.A)
Tortoiseecofin Acquisition C Shs Cl A (TRTL)
Battery Future Acquisition C Cl A Ord Shs (BFAC)

View all positions for Sandia Investment Management

Top funds holding Acelyrin

Citadel Advisors
Vanguard Group
Opaleye Management
OrbiMed Advisors
venBio Partners
Jpmorgan Chase & Co
Artal Group
Samsara BioCapital
Ikarian Capital
Blue Owl Capital Holdings
Henderson Group
Decheng Capital
Logos Global Management
Kynam Capital Management
Goldman Sachs Group

View all funds holding Acelyrin